30 October 2025
Bold Ideas, Bright Futures: Brilliance in Medical Affairs was the theme of this year’s joint Medical Affairs Professionals of Australasia (MAPA) and Medical Affairs Professional Society (MAPS) Australasia Medical Affairs Summit. The 2-day meeting was held on 24 and 25 September in Sydney, Australia, and welcomed over 300 attendees and 75 faculty members.
The need for an integrated, multidisciplinary approach to drug development, healthcare policy and decision-making was a recurring theme of the Westminster Business Forum Keynote Seminar on UK health life sciences, attended by Oxford PharmaGenesis this week in Whitehall, London, UK. This strongly supports the HealthScience concept developed by Oxford PharmaGenesis, which combines the clinical and…
A pioneering systematic methodology to identify observational data sources for specific needs has been presented by Oxford PharmaGenesis today at ISPOR’s 19th Annual International Meeting in Montreal, Canada.
A pioneering method to identify and recommend bespoke data sources for global programmes of real-world evidence is being presented at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).
Oxford PharmaGenesis™ will be showcasing its new HealthScience approach to demonstrating product value and achieving market access at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).
Oxford PharmaGenesis Value Demonstration Practice is proud to be an exhibitor once again at this year’s ISPOR International Meeting in Montreal, Canada.
Leading independent consultancy Oxford PharmaGenesis is pioneering the innovative discipline of HealthScience. For the first time, this integrates the clinical and scientific dimensions of healthcare with the economic, social, behavioural and political perspectives that determine the value of new medicines and health interventions.
